look2theblue Posted - 1 month ago

$BLUE Oh the stories on $TRIL are fascinating. Given $PFE stock price today, they'd be wise to do a deal with $BLUE particularly since the Trump administration has voiced support for Sickle Cell Disease cures. Would be a good way to stay in their good graces with RFK making noise about vaccines. Wouldn't want to own $MRNA today.

look2theblue Posted - 1 month ago

$BLUE The $TRIL story was one for the ages. Could that happen here, sure. It was a fun ride.

Xmarketsthestock Posted - 1 month ago

$AMGN $GILD $CERO $TRIL $$BMY

BloodyPortfolio Posted - 4 months ago

$VKTX No Fade for the shorts! It's happening here - $TRIL $IMGN.

RizKayBiznuts Posted - 4 months ago

$TRIL $cdt similarities abound

RKLB_Bull Posted - 4 months ago

$CDT back in 2020 Pfizer $PFE showed interest in $TRIL and acquired it in 2021 for 2B. And now $AZN is interested in $CDT and who knows will acquire in an year or so. So this cannot be unnoticed they must have researched on CDTs potential before giving them the recent deal. Think about it folks just don't fomo into news and sell short. In this market patience is needed and it pays in the end. My DD on this company looks solid so far and I'm long here with 233K shares. Will add huge on any dips if at all. My target price is 5$ not expecting in days or a months I can wait years for it. No urgency. I know how biotechs work and risks involved in it. My recent plays are ATOS and APLT I believed in them and banked

sharlena_cia_gov Posted - 07/28/24

$TRIL drop these people they a ponzi scheme

BloodyPortfolio Posted - 5 months ago

$VKTX I want $TRIL or $IMGN kind of movement. LFG!

soll Posted - 5 months ago

@NEWBIGTECH always watching, sitting on 100k shares. Watched $TRIL for 2+ years and owned 88k shares when their buyout was announced.

kamikaze_andy Posted - 05/30/24

$APDN Has the $TRIL at 0.30 feel to it right now. Resistance at 12$ - upcoming catalysts.

boilerrm04 Posted - 05/30/24

@Apr4609 @SuperCool5000 yup i would just like to add though, just bc og significant BP ownership doesnt guarantee success. $PFE invested in $Tril yes but 3 other duds at the same time like $FIXX which now became $Q32 so there are no guarantees but the investment a nice footnote.

beforethedeluge Posted - 7 months ago

Dough's tweet on X: BAIRD - nice nugget tonight on $LPTX As part of a $40M private placement in April, Gilead $GILD, Skorney) bought ~$15M in shares. A representative from Gilead is joining Leap's Scientific Advisory Board, which could help to cultivate a deeper scientific relationship. $TRIL 2.0👍

DeepDown Posted - 7 months ago

$ALLR this is another $TRIL in the making. watch out

DeepDown Posted - 7 months ago

$ALLR this is how $tril looks like back then.

DeepDown Posted - 7 months ago

$ALLR this is similar to $TRIL a few years ago. $pfe bought it for 2.3B

DeepDown Posted - 7 months ago

$ALLR remember one junky stock called $TRIL . It was trading at 0.25 at some time, but has decent cd47 assets. $PFE eventually bought it up for 2.3B, or 18.5 per share, cash. was in it

boilerrm04 Posted - 7 months ago

@GSMITH10107 i am still a bit weary just short term. $PFE bought $TRIL at $12.84 and rode it down to $4.89 so just bc big investment doesnt mean automatic home run but took a yearand a half and $PFE took them out at $18.44

AMbiotech Posted - 04/25/24

@VernCapital I’ve been following XA for years. The stock is at an all time low with an approved device. They had over two years to market and sell and rollout has been beyond slow. You can rave about insider buys all the time but no one cares anymore. CEO Lisi doesn’t know how to do a confernev call…he is asleep at the wheel and that’s not good for any company let alone a small cap bio. Was in $TRIL from and its day and night what a good CEO who cares about its shareholders can do for a company

Fraggs_Truffle Posted - 04/23/24

$TRIL,,,,,,,,,,,,, https://www.forbes.com/sites/jakezamansky/2013/08/08/the-great-vampire-squid-keeps-on-sucking/?sh=47c5415e7df8

ianchris Posted - 04/23/24

@samuelm7 @boilerrm04 I was in $TRIL too but was super happy with $17.50 as I owed 8k shares at a $3 avg in the end. The days in 2019 at $0.25 were terrifying tho…

boilerrm04 Posted - 8 months ago

$lptx i do remember one thing from The $tril days. They announced 6 new studies June 2020 when we were all hoping for buyout. Stock sank from $20 to $4.89. $pfe bought them out 2 months later in august for $18.44 so anything is possible.

STOP_Whining Posted - 8 months ago

@FE123 $TRIL had the same pattern just before getting bought out. Patience will pay off for investors in $IOVA

SpringGunner Posted - 8 months ago

$GOEV This reminds me of $TRIL from a couple of years ago. Just when they started getting results with their molecules article after article came out about their cash burn rate and them not making money. The message boards would fill up and go ballistic with negative comments every time they would give an investor update with good news and progress. YouTube had video after video saying there was no catalyst to make it move up and to get out. They ran it down to a little over $4 before Pfizer bought it out for $18.50. I got fat on that one. 10,000 shares at $5.23 Last year I remember an article on Canoo saying to sell and get out because the market for three wheeled vehicles was already saturated. Honestly, how low is the bar for these guys to get a writing job.

BrandNewLambo Posted - 03/26/24

$TRIL Been looking for the next Jan Svarka. Thinking David Lazar may be worth keeping an eye on at $OPGN

Koepkesd Posted - 03/22/24

@iBoughtTheWrongTicker THe $TRIL ticker doesn’t exist anymore. What happened with it? Epic rally?

Gunnar1 Posted - 8 months ago

@Steve_TheBull_Rogers Okay, here's some anecdotal evidence: I remember that around 2019/2020 it was also the case with $TRIL that IR never answered (ask @rockytrades). Then came the BO by Pfizer. Meanwhile at $TCON, the CEO himself responded a few times when Rocky mailed him. But all in all, it was a absolute shitshow. So the lesson is: never trust a company that reply to your emails. 😉

iBoughtTheWrongTicker Posted - 9 months ago

$ATOS if newbies come and click in the 3/6/12 mo chart and think ahhhh it’s already reached its potential it’s up 125% in a year - uhhh dudes this shit was up on less news in the $9’s, the market cap is still a measly $160M. When I had $TRIL at a dollar, and it ran to $7 people thought the same, and after P2 readout data, Pfizer scooped them up for $18.50. This is biopharm and it’s the riskiest segment but also the one with the most payoff. Multiples are expected, not your S&P average type gains. We are literally just getting started. And catalysts are RIGHT AROUND THE CORNER.

Metal_Health Posted - 9 months ago

@outNabout $BREA that 57 million volume gap will be filled and much more. This stock reminds me of $TRIL I started buying the hell out of that when it dropped from $4 to $1.75. $PFE acquired them in 2017 for $18.50/share.

iBoughtTheWrongTicker Posted - 9 months ago

@Lemonz32 @dcajic2 I’ve posted this before but $TRIL was picked up on positive data at P2…Pfizer didn’t seem to think twice about it. I held on all the way through the buyout at $18.50. My first share was picked up under $2…

iBoughtTheWrongTicker Posted - 9 months ago

@chrundrel lesson learned if you like what you’re seeing and you don’t need the money immediately and you monitor it daily why even have a SL…bios fluctuate to a much wider degree as other stocks but with great risk does occasionally come great reward. Held $TRIL straight through P2 data and buyout at $18.5 another oncology drug